A major European securities firm reiterated its Neutral rating on Kissei Pharmaceutical Co., Ltd. and cut its target price to ¥4,400. Consensus data as of the previous day is also provided.
On 27 October, a major European securities firm reiterated its Neutral rating on Kissei Pharmaceutical Co., Ltd. Meanwhile, its target price was cut to ¥4,400.
As of the previous day, 26 October, the rating consensus was 3.57 from 7 analysts, a "slightly bullish" level, while the target price consensus was ¥4,451.